TSXV/KNE (TSXV/KNE)

TSX Venture Exchange: TSXV/KNE · CAD

CA$0.04

+0.00 (0.0%)· Recorded snapshot

Market cap	7.2M
Revenue (ttm)	38.7K
Net income (ttm)	-2.7M
EPS (ttm)	-CA$0.02
Shares out	205.1M
Volume	234,000
Beta	0.24

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 38.7K
Net income (ttm): -2.7M
EPS (ttm): -CA$0.02
Market cap: 7.2M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-98.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSXV/KNE indicators

Market & fundamental data

Available fields

173

Groups with data

Currency

CAD

Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-27
Enterprise value	CAD 8.3M
Exchange	TSX Venture Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2001
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CA4838092084
Last earnings date	2025-11-28
Last refreshed	2026-10-29
Last stock split date	2017-03-13
Last stock split type	Reverse
Market cap	CAD 7.2M
Next earnings date	2026-11-27
Price	CAD 0.04
Price currency	CAD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	tsxv/KNE
Website	https://kanebiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-57.14%
EV/Sales	213.98x
FCF / EV yield	-30.16%
FCF yield	-34.82%
P/S ratio	185.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-0.04%
Operating margin	-6,794.22%
Pretax margin	-7,238.09%
ROA	-54.45%
ROA (5Y)	-49.39%
ROCE	788.74%
ROIC	-98.8%
SBC / revenue	395.21%
Tax / revenue	-258.07%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	2
Net income growth years	2
Revenue growth	-97.91%
Revenue growth (Q)	-70.92%
Revenue growth (QoQ)	-81.16%
Revenue growth 10Y	-12.38%
Revenue growth 5Y	-50.27%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD 0
Depreciation and amortization	CAD -662
EBIT	CAD -2.6M
EBITDA	CAD -2.6M
EPS	CAD -0.02
FCF per share	CAD -0.01
Financing cash flow	CAD 1.8M
Free cash flow	CAD -2.5M
Free cash flow minus SBC	CAD -2.7M
Gross profit	CAD -16
Income taxes	CAD -99,925
Investing cash flow	CAD -12,634
Net borrowing	CAD -72,290
Net cash flow	CAD -758,256
Net income	CAD -2.7M
Operating cash flow minus SBC	CAD -2.7M
Operating income	CAD -2.6M
Revenue	CAD 38,720
Stock-based compensation	CAD 153,024

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-27.49
Book value per share	CAD -0.00
Interest coverage	-14.28
Long-term assets	CAD 655,167
Long-term liabilities	CAD 660,329
Net cash (debt)	CAD -1.1M
Net cash / market cap	-15.44%
Piotroski F-Score	2
Property, plant and equipment	CAD 83,166
Shareholders' equity	CAD -993,863
Tangible book value	CAD -1.6M
Tangible book value per share	CAD -0.01
Total assets	CAD 2.2M
Total cash	CAD 854,729
Total debt	CAD 2M
Total liabilities	CAD 3.2M
WACC	5.97%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.01
Current assets	CAD 1.6M
Current liabilities	CAD 2.6M
Current ratio	0.61
Inventory turnover	0.1
Net working capital	CAD -540,685
Quick ratio	0.35
Working capital	CAD -988,701
Working capital turnover	-0.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-10.32%
Shareholder yield	-10.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-72%
10Y return CAGR	-11.95%
10Y total return	-72%
150-day SMA	CAD 0.03
15Y price change	-92.63%
15Y return CAGR	-15.96%
15Y total return	-92.63%
1D price change	0%
1M price change	16.67%
1M total return	16.67%
1W price change	16.67%
1W total return	16.67%
1Y price change	16.67%
1Y return CAGR	16.68%
1Y total return	16.67%
20-day SMA	CAD 0.03
200-day SMA	CAD 0.03
20Y price change	-98%
20Y return CAGR	-17.77%
20Y total return	-98%
3M price change	40%
3M total return	40%
3Y price change	-53.33%
3Y return CAGR	-22.43%
3Y total return	-53.33%
50-day SMA	CAD 0.03
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.05
52-week high date	2026-01-22
52-week low	CAD 0.02
52-week low date	2026-08-11
5Y price change	-78.79%
5Y return CAGR	-26.67%
5Y total return	-78.79%
All-time high	CAD 4.50
All-time high date	2005-01-13
All-time low	CAD 0.02
All-time low date	2026-08-11
Average true range (ATR)	CAD 0.00
Average volume	60.7K
Beta (1Y)	1.88
Beta (2Y)	0.6
Beta (5Y)	0.24
Change from 52-week high	-22.22%
Change from 52-week low	133.33%
Change from all-time high	-99.22%
Change from all-time low	133.33%
Change from open	16.67%
Day's gap	-14.29%
Dollar volume	CAD 8,190
High price	CAD 0.04
Low price	CAD 0.03
Monthly RSI	37.82
Open price	CAD 0.03
Position in 52-week range	100%
Previous close	CAD 0.04
Price vs 150-day SMA	10.41%
Price vs 20-day SMA	17.45%
Price vs 200-day SMA	7.36%
Price vs 50-day SMA	24.11%
Relative volume	3.86
RSI	61.37
Sharpe ratio	0.66
Sharpe ratio (3Y)	0.3
Sharpe ratio (5Y)	0.25
Sortino ratio	1.11
Sortino ratio (3Y)	0.51
Sortino ratio (5Y)	0.44
Volume	234K
Weekly RSI	54.16
YTD price change	-12.5%
YTD total return	-12.5%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	113.5M
Shares change (QoQ)	-54.16%
Shares change (YoY)	10.32%
Shares held by insiders	44.64%
Shares outstanding	205.1M

Deeper analysis on TSXV/KNE

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSXV/KNE report

Is a complete TSXV/KNE research report available?

No complete published report is available for tsxv/KNE (TSXV/KNE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/KNE (TSXV/KNE)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/KNE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/KNE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSXV/KNE

Frequently asked questions